Nanoporous Metallic Canister for Cell Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cellular and biotherapeutic delivery methods face challenges such as immune rejection, inflammation, and structural limitations, leading to reduced efficacy and safety concerns due to the use of polymeric materials that trigger adverse reactions and are prone to manufacturing defects.
Innovation Solution
A biocompatible metallic canister with a nanoscale through-porous and bicontinuous membrane morphology is developed, allowing controlled diffusion of therapeutic agents while minimizing immune response and maintaining structural integrity, utilizing medical-grade metals processed for corrosion resistance and surface modification to promote vascularization and reduce inflammation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If polymeric materials are used for cellular and biotherapeutic delivery, then flexibility and ease of manufacture are improved, but immune rejection and inflammation increase
Solution Approach 1:
The patent employs a nanoporous metallic membrane as the delivery device structure. The porous configuration enables controlled diffusion of therapeutic agents while the metallic material composition provides biocompatibility and resistance to immune rejection, eliminating the inflammatory response associated with polymeric materials.
Solution Approach 2:
The invention utilizes a composite structure combining nanoporous metallic membrane with specific material properties. The metallic base material provides structural integrity and biocompatibility, while the nanoporous configuration enables controlled release, creating a composite system that overcomes the limitations of single-material polymeric devices.
2Ease of manufacture
If polymeric materials are used for cellular and biotherapeutic delivery, then ease of manufacture is improved, but structural integrity and reliability deteriorate
Solution Approach 1:
The nanoporous metallic membrane provides a structurally robust framework that maintains mechanical integrity while enabling controlled diffusion. The metallic material's inherent strength and stability overcome the structural weaknesses of polymeric materials, ensuring reliable long-term performance of the delivery device.
3Device complexity
If traditional delivery methods are used, then simplicity is maintained, but controlled release and long-term secretion capability are reduced
Solution Approach 1:
The nanoporous metallic membrane's porous structure enables sustained controlled release of therapeutic agents over extended periods. The high surface area to volume ratio of the nanoporous structure, combined with its biocompatible metallic material, facilitates long-term secretion capability while maintaining a relatively simple device architecture.
4Device complexity
If direct cell transplantation is performed, then simplicity is maintained, but immune response and cell survival rate worsen
Solution Approach 1:
The nanoporous metallic membrane serves as a protective barrier that shields transplanted cells from immune system attack. The porous structure allows nutrient and waste exchange while preventing immune cell infiltration, thereby enhancing cell survival rates without requiring complex immunosuppression protocols.
Solution Approach 2:
The metallic nanoporous membrane acts as an intermediary between the transplanted cells and the host immune system. This intermediate barrier structure physically separates the therapeutic cells from immune cells while maintaining physiological exchange, reducing direct immune recognition and rejection of the transplanted cells.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The metallic canister provides a stable environment for long-term secretion of bioactive factors, reduces immune rejection, and enhances the survival and function of therapeutic cells and agents, addressing the limitations of polymeric delivery systems by ensuring controlled release and structural robustness.
Implementation Method 1
allowing controlled diffusion of therapeutic agents while minimizing immune response
Implementation Method 2
surface modification to promote vascularization and reduce inflammation
Implementation Method 3
A biocompatible metallic canister with a nanoscale through-porous and bicontinuous membrane morphology is developed, allowing controlled diffusion of therapeutic agents while minimizing immune response
Data Source
AI summary
The invention relates to a metallic, nanoporous canister used to encapsulate cellular and/or biotherapeutic agents. The device is biocompatible and functions to wholly isolate a therapeutically active agent and/or cells therein. Their implantation, and survival in vivo, permits the local or systemic diffusion of their encapsulated cellular and/or biomolecular and therapeutics factors with the potential to promote repair of damaged or degenerated tissues in mammalian hosts, primarily humans.